Skip over generic navigation
Skip over primary navigation
Skip over visual
Evonik is one of the world's leading specialty chemicals companies.
Skip over functional column
Around 80 percent of sales come from market-leading positions, which we are systematically expanding. We concentrate on high-growth megatrends, especially health, nutrition, resource efficiency and globalization. As part of our ambitious growth strategy, we are also stepping up our presence in emerging markets, especially in Asia. Important competitive advantages come from our integrated technology platforms, which we continuously refine.
Our strengths include the balanced spectrum of our business activities, end-markets and regions, and working closely with customers. Market-oriented research and development is an important driver of our profitable growth. Financial discipline and continuous improvement of our cost base are also very important.
Our operations are grouped in three segments - Nutrition & Care, Resource Efficiency and Performance Materials - which are run as independent companies operating as entrepreneurs within the enterprise. The Services segment provides site services and administrative services. The Executive Board concentrates on Evonik's strategic development within a management holding structure.
We accept responsibility - for our business, our employees, the environment and society. We are systematically extending the contribution we make to sustainable development through resource-saving products and solutions, and continuous improvement of our processes.
Shares in Evonik are traded on the stock exchange in Frankfurt am Main (Prime Standard) and are included in the MDAX and DJ STOXX Europe 600 share indices. They are also included in prestigious sustainability indices. Evonik is positioned among the leaders in the chemical sector in important sustainability ratings.
In 2015 Evonik’s more than 33,500 employees generated sales of €13.5 billion and adjusted EBITDA of €2.47 billion. The adjusted EBITDA margin was 18.2 percent and ROCE was 16.6 percent, so we once again earned an attractive premium on the cost of capital. More than 80 percent of sales are generated outside Germany, providing convincing evidence that our business is global.